Navigation Links
Multiple sclerosis patients have lower risk of cancer: UBC-VCH research
Date:6/21/2012

Multiple sclerosis (MS) patients appear to have a lower cancer risk, according to a new study led by researchers at the University of British Columbia and Vancouver Coastal Health.

The study, published in the current issue of the journal Brain, is the first to investigate overall cancer risk in MS patients in North America.

"Because the immune system plays important roles in both cancer and MS, we wanted to know whether the risk of cancer is different for people with MS," says Elaine Kingwell, the study's lead author and a postdoctoral fellow in the UBC Faculty of Medicine and Brain Research Centre at UBC and VCH Research Institute. "Not only did MS patients have a lower overall cancer risk, the risk for colorectal cancer in particular was significantly lower."

The researchers compared the diagnoses of cancer in MS patients in British Columbia with those of the general population. While they found that MS patients have a lower risk in general for cancer and in particular for colorectal cancer they found that the risks for brain cancer and bladder cancer were slightly elevated (albeit not significantly). In patients with relapsing-onset MS, the risk for non-melanoma skin cancer was significantly greater.

Further studies will be needed to understand the reasons for this reduced overall cancer risk.

An unexpected finding was that for those who did develop cancer, tumour size tended to be larger at time of diagnosis. More work is needed to determine why some tumours might be caught later in people with MS.

"Because the symptoms of MS can be broad and include feelings of fatigue, it's possible the symptoms of cancer are being masked or overlooked," says Helen Tremlett, the study's senior author and an associate professor in the UBC Faculty of Medicine. She adds that, regardless of the findings, MS patients and their physicians are encouraged to follow cancer screening guidelines. Her team is planning a follow up study to determine whether death rates due to cancer are altered in MS patients.


'/>"/>

Contact: Melissa Ashman
mashman@brain.ubc.ca
604-827-3396
University of British Columbia
Source:Eurekalert

Related medicine news :

1. Lenalidomide prolongs disease control for multiple myeloma patients after stem cell transplant
2. Pot Might Help Ease Multiple Sclerosis Symptoms
3. FDA Issues Multiple Sclerosis Drug Alert
4. Study shows benefit of new maintenance therapy for multiple myeloma
5. Multiple thought channels may help brain avoid traffic jams
6. Low-dose whole-body CT finds disease missed on standard imaging for patients with multiple myeloma
7. Kessler Foundation scientist awarded $554,000 for multiple sclerosis employment research
8. Fish Oil Supplements Wont Help in Multiple Sclerosis: Study
9. Experimental Pill for Multiple Sclerosis Shows Promise
10. Scientists uncover multiple faces of deadly breast cancer
11. Haematopoietic stem cell transplantation increases survival in systemic sclerosis patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... ... Why does the prevalence of obesity continue to increase worldwide? Some would say lifestyle, ... cause of obesity in his new book “Body Weight Regulation.” , “Body Weight ... healthy life. Proietto said understanding the regulation of body weight and the causes of ...
(Date:12/6/2016)... Alpharetta, GA (PRWEB) , ... December 06, 2016 ... ... list of largest patient satisfaction measurement firms. The ranking is based on ... healthcare organizations such as hospitals, health systems, ambulatory surgical centers, clinically integrated networks, ...
(Date:12/6/2016)... ... December 06, 2016 , ... Public middle ... 15, 2017 to apply for a 2016/2017 California Casualty Thomas R. Brown Athletics ... Qualifying schools can receive up to $3,000. , The grant is named ...
(Date:12/6/2016)... ... December 06, 2016 , ... United ... to announce it has added CXC Solutions (CXC) as a new Strategic Partner. ... solutions are tailored to help benefits advisors reduce operating costs and generate additional ...
(Date:12/6/2016)... ... December 06, 2016 , ... Gateway Analytical, one of the ... counting and sizing services for USP 788 and 789 particulate standards compliance. The ... a response to the needs of pharmaceutical and medical device manufacturers, who are ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... , Dec. 6, 2016 Two new disaster ... in a simulated mass casualty event Tuesday at John ... The technology debuted before an audience including ... representatives from Homeland Security, Federal Law Enforcement Agencies, and ... known as HiRO (Health Integrated Rescue Operations), was developed ...
(Date:12/6/2016)... 6, 2016  Regulus Therapeutics Inc. (NASDAQ: ... discovery and development of innovative medicines targeting microRNAs, ... its R&D day, held in New ... an anti-miR targeting microRNA-27 (miR-27) for the treatment ... an anti-miR targeting microRNA-17 (miR-17) for the treatment ...
(Date:12/6/2016)... DIEGO , Dec. 6, 2016 /PRNewswire/ ... on the development of Conditionally Active Biologic ... and Beijing Sinobioway Group Company, Limited (Sinobioway) ... for development.  The specific program candidates and ... March 2015, BioAtla and Sinobioway entered into ...
Breaking Medicine Technology: